| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Department of Immunology, Division of Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom;
Medical Molecular Biology Unit, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand;
Pediatric Department, Khon Kaen Hospital, Ministry of Public Health, Khon Kaen, Thailand;
Medical Biotechnology Unit, National Centre for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Patumthani, Thailand;
¶ The Division of Structure Biology, The Wellcome Trust Centre for Human Genetic, Roosevelt Drive, Oxford, United Kingdom; and
|| Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
Dengue virus infection poses a growing public health and economic burden in a number of tropical and subtropical countries. Dengue circulates as a number of quasispecies, which can be divided by serology into four groups or serotypes. An interesting feature of Dengue, recognized over five decades ago, is that most severe cases that show hemorrhagic fever are not suffering from a primary infection. Instead, they are reinfected with a virus of different serotype. This observation poses considerable problems in vaccine design, and it is therefore imperative to gain a full understanding of the mechanisms underlying this immunological enhancement of disease. In this study, we examined a T cell epitope restricted by HLA-A*24, a major MHC class I allele, in Southeast Asia in a cohort of children admitted to a hospital with acute Dengue infection. The cytokine profiles and the degranulation capacity of T cells generated to this epitope are defined and compared across different viral serotypes. Cross-reactive Dengue-specific T cells seem to show suboptimal degranulation but high cytokine production, which may contribute to the development of the vascular leak characteristic of Dengue hemorrhagic fever.
This article has been cited by other articles:
|
|
 |
|
  B. E. E. Martina, P. Koraka, and A. D. M. E. Osterhaus Dengue Virus Pathogenesis: an Integrated View Clin. Microbiol. Rev., October 1, 2009; 22(4): 564 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gil, C. Lopez, L. Lazo, I. Valdes, E. Marcos, R. Alonso, A. Gambe, J. Martin, Y. Romero, M. G. Guzman, et al. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice Int. Immunol., October 1, 2009; 21(10): 1175 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Yauch, R. M. Zellweger, M. F. Kotturi, A. Qutubuddin, J. Sidney, B. Peters, T. R. Prestwood, A. Sette, and S. Shresta A Protective Role for Dengue Virus-Specific CD8+ T Cells J. Immunol., April 15, 2009; 182(8): 4865 - 4873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Dejnirattisai, T. Duangchinda, C.-L. S. Lin, S. Vasanawathana, M. Jones, M. Jacobs, P. Malasit, X.-n. Xu, G. Screaton, and J. Mongkolsapaya A Complex Interplay among Virus, Dendritic Cells, T Cells, and Cytokines in Dengue Virus Infections J. Immunol., November 1, 2008; 181(9): 5865 - 5874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Hershkovitz, A. Zilka, A. Bar-Ilan, S. Abutbul, A. Davidson, M. Mazzon, B. M. Kummerer, A. Monsoengo, M. Jacobs, and A. Porgador Dengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK Cells J. Virol., August 1, 2008; 82(15): 7666 - 7676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Parsons, A. Lelic, L. Hayes, A. Carter, L. Marshall, C. Evelegh, M. Drebot, M. Andonova, C. McMurtrey, W. Hildebrand, et al. The Memory T Cell Response to West Nile Virus in Symptomatic Humans following Natural Infection Is Not Influenced by Age and Is Dominated by a Restricted Set of CD8+ T Cell Epitopes J. Immunol., July 15, 2008; 181(2): 1563 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blackley, Z. Kou, H. Chen, M. Quinn, R. C. Rose, J. J. Schlesinger, M. Coppage, and X. Jin Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro J. Virol., December 15, 2007; 81(24): 13325 - 13334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Appanna, T. L. Huat, L. L. C. See, P. L. Tan, J. Vadivelu, and S. Devi Cross-Reactive T-Cell Responses to the Nonstructural Regions of Dengue Viruses among Dengue Fever and Dengue Hemorrhagic Fever Patients in Malaysia Clin. Vaccine Immunol., August 1, 2007; 14(8): 969 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Clyde, J. L. Kyle, and E. Harris Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis J. Virol., December 1, 2006; 80(23): 11418 - 11431. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
